CVS vs. ALHC: Which Medicare Advantage Stock Is the Better Pick Now?
CVS Health outpaces Alignment Healthcare with stronger returns, rising earnings estimates and a lower valuation as Aetna???s turnaround gains traction.
Alignment Healthcare: The Drawdown I Told You To Wait For Has Arrived (Rating Upgrade)
Alignment Healthcare is upgraded from Hold to Buy after a 38% valuation-driven drawdown, despite continued operational outperformance. Q2 results delivered record-low medical benefits ratio, 31% membership growth, 48% adjusted EBITDA growth, and raised full-year guidance. ALHC now trades at 29x 2026 EPS and 0.5x forward sales, with a fair value in the low-to-mid $20s, implying 40%+ upside.
Can ALHC's Raised 2026 Outlook Offset Heavier Second-Half Spending?
Alignment Healthcare raises its 2026 outlook as membership and medical-cost trends improve, but heavier second-half investments could pressure near-term profitability.
Is ALHC Stock a Buy as Fast Growth Clashes With Premium Valuation?
Alignment Healthcare lifted its 2026 outlook after 31%+ membership and revenue growth, but rich earnings valuation and second-half risks may justify a wait-and-see approach.
Down 37.6% in 4 Weeks, Here's Why Alignment Healthcare (ALHC) Looks Ripe for a Turnaround
Alignment Healthcare (ALHC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Alignment Healthcare, Inc. (ALHC) Q2 2026 Earnings Call Transcript
Alignment Healthcare, Inc. (ALHC) Q2 2026 Earnings Call Transcript
Compared to Estimates, Alignment Healthcare (ALHC) Q2 Earnings: A Look at Key Metrics
The headline numbers for Alignment Healthcare (ALHC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Alignment Healthcare (ALHC) Beats Q2 Earnings and Revenue Estimates
Alignment Healthcare (ALHC) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.07 per share a year ago.
Alignment Healthcare Q2 Earnings Call Highlights
Alignment Healthcare NASDAQ: ALHC reported second-quarter growth in membership, revenue and adjusted EBITDA, while raising the low end of its full-year profitability outlook and increasing its membership expectations for 2026.
Alignment Healthcare Turns Profit As Insurer Gets Handle On Costs
Alignment Healthcare's second quarter net income more than doubled to $36.6 million compared to the year ago period as costs of care for older adults in its Medicare Advantage plans eased.
Reasons to Retain Alignment Healthcare Stock in Your Portfolio for Now
ALHC's AI and automation are boosting margins and efficiency, but CMS risk model changes and revenue timing cloud near-term earnings visibility.
ALHC Trends to Watch as AI Automation Reshapes Medicare Economics
Alignment Healthcare is using AI automation, quality plans and complex-care growth to improve Medicare Advantage economics while cost and rule pressures remain.
